Cite Filings / SABS / 0001493152-21-026918
Feed Companies Filings Check
Sign in
SC 13D

Beneficial Ownership Report

SAB Biotherapeutics, Inc. · Filed 2021-11-02 · Acc 0001493152-21-026918

Documents 1

  • SC 13D Beneficial Ownership Report , sc-13d.htm

Around this filing

  • 2021-11-02 SC 13D Beneficial Ownership Report
  • 2021-11-01 SC 13D Beneficial Ownership Report
  • 2021-11-01 SC 13D Beneficial Ownership Report
  • 2021-10-28 8-K Material agreement · Acquisition or sale completed · Unregistered share sale · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Shell status change
  • 2021-10-26 4 Options or other derivatives
  • 2021-10-26 4 Options or other derivatives
  • 2021-10-26 3 Initial Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Vivo Opportunity Fund Holdings, L.P. 9.99%
  2. 2026-11-16 SCHEDULE 13G/A · BALYASNY ASSET MANAGEMENT L.P. 7.94%
  3. 2026-11-16 SCHEDULE 13G/A · Woodline Partners LP 5.7%
Loading sc-13d.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…